ULTRAVAC 5+1 Se B12

Country: New Zealand

Language: English

Source: Ministry for Primary Industries

Active ingredient:

clostridium perfringens type d toxoid; clostridium tetani toxoid; clostridium chauvoei toxoid/cells; corynebacterium pseudotuberculosis cells; clostridium novyi type b toxoid/cells; selenium; clostridium septicum toxoid; hydroxocobalamin acetate

Available from:

Zoetis New Zealand Limited

Composition:

clostridium perfringens type d toxoid 0 vaccine; clostridium tetani toxoid 0 vaccine; clostridium chauvoei toxoid/cells 0 vaccine; corynebacterium pseudotuberculosis cells 0 vaccine; clostridium novyi type b toxoid/cells 0 vaccine; selenium 1 g/litre; clostridium septicum toxoid 0 vaccine; hydroxocobalamin acetate 2 g/litre

Therapeutic area:

Vaccine

Authorization date:

2018-10-29

Summary of Product characteristics

REGISTRANT:
Zoetis New Zealand Limited, 8 Mahuhu Crescent, Auckland
TRADE NAME:
Ultravac 5+1 Se B12
ACVM NO.:
A11606
PREPARATION DATE:
11 April 2023
PAGE:
1 of 9
PILLOWPACK LABEL
MAIN PANEL
WARNING - KEEP OUT OF REACH OF CHILDREN
FOR ANIMAL TREATMENT ONLY
ULTRAVAC
® 5+1 SE B12 VACCINE
_C. PSEUDOTUBERCULOSIS_ (_OVIS_) ≥ 6 CPU/ML, _CL. PERFRINGENS_ TYPE
D ≥ 5 IU/ML, _CL._ _TETANI_ ≥ 2.5
IU/ML, _CL. NOVYI_ TYPE B ≥ 3.5 IU/ML, _CL. SEPTICUM_ ≥ 2.5 IU/ML
(AS ULTRAFILTERED TOXOIDS), _CL. _
_CHAUVOEI_ (MEETS PH. EUR.) AS FORMOL CULTURE, 1 MG/ML SELENIUM, 2
MG/ML
HYDROXOCOBALAMIN.
0.1 mg/mL Thiomersal is added as a preservative._ _
READ THE ENCLOSED LEAFLET FOR FULL INSTRUCTIONS
DIRECTIONS FOR USE
DOSAGE AND ADMINISTRATION
SHAKE WELL BEFORE USE AND KEEP THOROUGHLY MIXED DURING USE
For Subcutaneous Use Only
Dose: Sheep and Lambs 1 mL
[label identifier]
WITHHOLDING PERIODS: NIL
FIRST AID: If poisoning occurs, contact a doctor or National Poisons
Centre. Phone New Zealand
0800 POISON (0800 764 766).
STORAGE: Store between 2
o
C and 8
o
C (Refrigerate. Do not freeze). Protect from light. Prolonged
exposure to light will have an adverse effect on Vitamin B12.
ACVM NO. A11606
(B) XXXX-
EXPIRY
mth/yr
BOTTLE LABEL
SIDE PANEL
250 [500]_ _DOSES
250 [500] ML
Zoetis New Zealand Ltd
8 Mahuhu Crescent
Auckland
NEW ZEALAND
[Zoetis logo]
REGISTRANT:
Zoetis New Zealand Limited, 8 Mahuhu Crescent, Auckland
TRADE NAME:
Ultravac 5+1 Se B12
ACVM NO.:
A11606
PREPARATION DATE:
11 April 2023
PAGE:
2 of 9
CARTON
MAIN PANEL
WARNING - KEEP OUT OF REACH OF CHILDREN
FOR ANIMAL TREATMENT ONLY
[Sheep graphic]
ULTRAVAC
® 5+1 SE B12 VACCINE
_C. PSEUDOTUBERCULOSIS_ (_OVIS_) > 6 CPU/ML_, CL. PERFRINGENS_ TYPE D
≥ 5 IU/ML_, CL. TETANI _ ≥ 2.5
IU/ML_, CL. NOVYI_ TYPE B ≥ 3.5 IU/ML_, CL. SEPTICUM_ ≥ 2.5 IU/ML_
_(AS ULTRAFILTERED TOXOIDS)_, CL. _
_CHAUVOEI_ (MEETS PH. EUR.)_ _AS FORMOL CULTURE, 1 MG/ML SELENIUM, 2
MG/ML
HYDROXOCOBALAMIN.
0.1 mg/mL Thiomersal is added as a preservative.
FOR THE CONTROL OF CASEOUS LYMPHADENITIS (CLA OR CHEES